Cyclophosphamide and Prednisone Followed by Methotrexate To Treat Vasculitides - Related Studies

Cyclophosphamide and Prednisone Followed by Methotrexate To Treat Vasculitides

This study has been completed.

Study NCT00001473. Last updated on March 3, 2008. Information provided by National Institutes of Health Clinical Center (CC)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Vasculitis
		Wegener's Granulomatosis

2	Additional conditions recognized in this trial
		Wegener Granulomatosis

3	More general conditions related to this trial
		Cardiovascular Diseases
		Kidney Diseases
		Lung Diseases
		Lung Diseases, Interstitial
		Respiratory Tract Diseases
		Urologic Diseases
		Vascular Diseases

4	Additional drug interventions recognized in this trial
		Cyclophosphamide
		Methotrexate

5	More general drug interventions related to this trial
		Abortifacient Agents
		Abortifacient Agents, Nonsteroidal
		Alkylating Agents
		Antimetabolites
		Antimetabolites, Antineoplastic
		Antineoplastic Agents
		Antineoplastic Agents, Alkylating
		Antirheumatic Agents
		Dermatologic Agents
		Enzyme Inhibitors
		Folic Acid Antagonists
		Immunologic Factors
		Immunosuppressive Agents
		Molecular Mechanisms of Pharmacological Action
		Myeloablative Agonists
		Nucleic Acid Synthesis Inhibitors
		Pharmacologic Actions
		Physiological Effects of Drugs
		Reproductive Control Agents
		Therapeutic Uses

6	Sponsors listed in this trial
		National Institute of Allergy and Infectious Diseases (NIAID)